, Tracking Stock Market Picks
Enter Symbol:
Rating: PKI
Buy $58
up 22.00 %

Perkinelmer, Inc. (NYSE: PKI) reiterated to Buy with price target $58 by Mizuho

Friday,  May 1, 2015  8:25 AM ET by Betsy O'Brien Harrison

Mizuho reiterated Perkinelmer, Inc. (NYSE: PKI) to Buy with price target $58. Previously Mizuho reiterated Perkinelmer, Inc. (NYSE: PKI) to Buy with price target
$50 on 01/31/2014, when the stock price was $43.60. Since then, Perkinelmer, Inc.'s stock price has gained 22% as of 05/01/2015's recent price of $53.31.
If you would have followed the previous Mizuho's recommendation on PKI, you would have gained 22% of your investment in 455 days.

Perkinelmer, Inc. is a provider of technology, services and solutions to the diagnostics, academic research, environmental monitoring and safety and security markets. During the fiscal year ended December 28, 2008 (fiscal 2008), the Company operated in two segments: Life and Analytical Sciences, and Optoelectronics. Subsequent to the fiscal 2008, the Company operates in two segments: Human Health and Environmental Health. In January 2009, it acquired Opto Technology Inc. (Opto Technology). In December 2008, the Company acquired Arnel, Inc. (Arnel). In December 2008, it shut down the Cellular Screening Fluorescence and Luminescence workstations business, Analytical Proteomics Instruments business, and Proteomics and Genomics Instruments business. In May 2009, the Company acquired Analytica of Branford, Inc. In September 2009, the Company acquired the genetic screening business of Surendra Genetic Labs, Pvt Ltd. and SYM-BIO Lifescience.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy